137 related articles for article (PubMed ID: 10893159)
1. The internal rotavirus protein VP6 primes for an enhanced neutralizing antibody response.
Esquivel FR; Lopez S; Guitierrez-X L; Arias C
Arch Virol; 2000; 145(4):813-25. PubMed ID: 10893159
[TBL] [Abstract][Full Text] [Related]
2. Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Basu M; Rae MN; McNeal MM; Ward RL
Virology; 1998 Oct; 250(1):230-40. PubMed ID: 9770437
[TBL] [Abstract][Full Text] [Related]
3. Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.
Choi AH; Basu M; McNeal MM; Clements JD; Ward RL
J Virol; 1999 Sep; 73(9):7574-81. PubMed ID: 10438847
[TBL] [Abstract][Full Text] [Related]
4. Homotypic protection against rotavirus-induced diarrhea in infant mice breast-fed by dams immunized with the recombinant VP8* subunit of the VP4 capsid protein.
Gil MT; de Souza CO; Asensi M; Buesa J
Viral Immunol; 2000; 13(2):187-200. PubMed ID: 10892999
[TBL] [Abstract][Full Text] [Related]
5. Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines.
Yuan L; Ishida S; Honma S; Patton JT; Hodgins DC; Kapikian AZ; Hoshino Y
J Infect Dis; 2004 May; 189(10):1833-45. PubMed ID: 15122520
[TBL] [Abstract][Full Text] [Related]
6. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
7. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4, VP6, and VP7 induces CD8+ T lymphocytes that mediate clearance of chronic rotavirus infection in SCID mice.
Dharakul T; Labbe M; Cohen J; Bellamy AR; Street JE; Mackow ER; Fiore L; Rott L; Greenberg HB
J Virol; 1991 Nov; 65(11):5928-32. PubMed ID: 1656079
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.
Feng N; Lawton JA; Gilbert J; Kuklin N; Vo P; Prasad BV; Greenberg HB
J Clin Invest; 2002 May; 109(9):1203-13. PubMed ID: 11994409
[TBL] [Abstract][Full Text] [Related]
9. Particle bombardment-mediated DNA vaccination with rotavirus VP6 induces high levels of serum rotavirus IgG but fails to protect mice against challenge.
Choi AH; Knowlton DR; McNeal MM; Ward RL
Virology; 1997 May; 232(1):129-38. PubMed ID: 9185596
[TBL] [Abstract][Full Text] [Related]
10. Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4.
Ijaz MK; Alkarmi TO; el-Mekki AW; Galadari SH; Dar FK; Babiuk LA
Vaccine; 1995 Mar; 13(4):331-8. PubMed ID: 7793126
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M; Cai L
Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
[TBL] [Abstract][Full Text] [Related]
12. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
[TBL] [Abstract][Full Text] [Related]
13. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
[TBL] [Abstract][Full Text] [Related]
14. Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
Yang K; Wang S; Chang KO; Lu S; Saif LJ; Greenberg HB; Brinker JP; Herrmann JE
Vaccine; 2001 Apr; 19(23-24):3285-91. PubMed ID: 11312027
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity induced by rotavirus DNA vaccines.
Chen SC; Fynan EF; Robinson HL; Lu S; Greenberg HB; Santoro JC; Herrmann JE
Vaccine; 1997 Jun; 15(8):899-902. PubMed ID: 9234543
[TBL] [Abstract][Full Text] [Related]
16. Identification of a T-helper cell epitope on the rotavirus VP6 protein.
Baños DM; Lopez S; Arias CF; Esquivel FR
J Virol; 1997 Jan; 71(1):419-26. PubMed ID: 8985366
[TBL] [Abstract][Full Text] [Related]
17. Heterotypic passive protection induced by synthetic peptides corresponding to VP7 and VP4 of bovine rotavirus.
Ijaz MK; Attah-Poku SK; Redmond MJ; Parker MD; Sabara MI; Frenchick P; Babiuk LA
J Virol; 1991 Jun; 65(6):3106-13. PubMed ID: 1851871
[TBL] [Abstract][Full Text] [Related]
18. Viral proteins VP2, VP6, and NSP2 are strongly precipitated by serum and fecal antibodies from children with rotavirus symptomatic infection.
Colomina J; Gil MT; Codoñer P; Buesa J
J Med Virol; 1998 Sep; 56(1):58-65. PubMed ID: 9700634
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccines against rotavirus infections.
Herrmann JE; Chen SC; Fynan EF; Santoro JC; Greenberg HB; Robinson HL
Arch Virol Suppl; 1996; 12():207-15. PubMed ID: 9015117
[TBL] [Abstract][Full Text] [Related]
20. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children.
Gorrell RJ; Bishop RF
J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
